Related by context. Frequent words. (Click for all words.) 61 Companies Mentioned 59 DILIGENCE BEFORE INVESTING IN 59 Joint Surg Am 59 TH STAFF WRITER 58 AP Photo BAG# 58 EXECUTIVE SUMMARY 58 Product Overview 57 Recent Past 57 J Am Coll 56 ejp 56 By Mannix Porterfield 56 Factors Influencing 55 J Bone 55 Report Contents 55 Für den Inhalt der 55 BY MICHAEL ROSENBERG 55 EDGAR Online via COMTEX 55 jlw 55 Reportlinker Adds Global 55 Am J Physiol 54 Increases Risk 54 Cardiol 54 vlb 53 SHARE OF 53 folgenden Meldung ist nicht 53 TR Staff Writer 53 ITZKOVICH 53 Market Segments Industry Concentration 53 Reduce Risk 53 Bulletin Staff Writer 53 Announces Publication 53 Suppl 53 Study Confirms 53 Announces Initiation 53 QUERIES PLEASE CONTACT 52 3 Product Definitions 52 Key Findings 52 Gain Insight 52 APPENDIX 52 Production Capacity 52 Report Examines 52 ANALYSIS OF 52 BY OPERATOR Chart 52 A.Market Analysis III 51 TIMES REPUBLICAN 51 #/#/# Calendar Spread [002] 51 Independently Analyzed 51 die Verivox GmbH sondern 51 suppl 51 Competitive Landscape 51 è'ç ½ é é 51 Abstract Full Text 51 • kpetrie@stcloudtimes.com • 51 Am J Respir 51 Aarkstore Enterprise 51 FDA Warns 51 olp 50 Study Examines 50 MPH WITH GUSTS 50 Shows Promise 50 Risk Ranking Declines 50 Study Reveals 50 grams dietary fiber 50 ½ å ¯ ¼ 50 visit http:/www.researchandmarkets.com/reports/c#anthracyclines 50 Risk Overview 50 Download PDF 50 Relationship Between 49 Bullish Engulfing Pattern 49 Raw Sky5 Video 49 +# mins #.#secs A8 49 Geographic Region Country 49 Receives FDA Clearance 49 full Prescribing Information 49 Corporate Developments 49 +# mins #.#secs M 49 Detailed Product 49 Introduces Next Generation 49 Receives Order 49 Key Topics Covered 49 月 49 DESK ON TEL 49 Chart II 48 AS AMENDED 48 Outpace 48 Dollars Unaudited 48 Distribution Channels 48 THE BEST FANZINE 47 Thousand Tons 47 #:#-# [022] 47 Detailed Analysis 47 % 2Fmedia.washingtonpost.com 47 grams carbohydrate 47 BY JIM BAUMBACH 47 Reports Positive 47 UK Regulatory Announcement 47 Growth Slows 47 Long Term Projections 47 Prescribing Information 47 Chart III 47 B.Market Analytics III